Blue Trust’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2M Sell
12,409
-5,102
-29% -$850K 0.02% 193
2026
Q2
$3.32M Buy
17,511
+3,408
+24% +$641K 0.03% 142
2026
Q1
$2.78M Buy
14,103
+5,106
+57% +$985K 0.03% 150
2025
Q4
$1.65M Sell
8,997
-568
-6% -$100K 0.02% 214
2025
Q3
$1.47M Buy
9,565
+329
+4% +$49.8K 0.02% 222
2025
Q2
$1.29M Sell
9,236
-1,474
-14% -$207K 0.02% 226
2025
Q1
$1.57M Buy
10,710
+826
+8% +$120K 0.02% 189
2024
Q4
$1.3M Sell
9,884
-129
-1% -$18.1K 0.02% 204
2024
Q3
$1.56M Buy
10,013
+5,827
+139% +$941K 0.02% 193
2024
Q2
$567K Buy
4,186
+2,987
+249% +$449K 0.01% 337
2024
Q1
$162K Sell
1,199
-732
-38% -$96.9K ﹤0.01% 574
2023
Q4
$262K Sell
1,931
-354
-15% -$46K ﹤0.01% 369
2023
Q3
$327K Buy
2,285
+823
+56% +$112K 0.01% 324
2023
Q2
$203K Sell
1,462
-1,220
-45% -$180K ﹤0.01% 361
2023
Q1
$363K Buy
2,682
+71
+3% +$9.6K 0.01% 362
2022
Q4
$286K Buy
2,611
+1,455
+126% +$182K 0.01% 363
2022
Q3
$153K Buy
1,156
+78
+7% +$9.9K ﹤0.01% 395
2022
Q2
$143K Buy
+1,078
New +$141K ﹤0.01% 396

Other funds holding AZN

Blue Trust's AZN Position: Q3 2026 in Review

Blue Trust reduced its AstraZeneca (AZN) stake by 29% in Q3 2026, selling an estimated $850K and leaving 12,409 shares worth $2M. The position accounts for 0.02% of the portfolio, ranked #193.

Blue Trust first reported a position in AZN in Q2 2022 and has held it in 18 quarters since. The position peaked at $3.32M in Q2 2026. 1,222 funds tracked by Wall St. Rank hold AZN as of Q3 2026.

  • Blue Trust held 12,409 shares of AstraZeneca worth $2M as of Q3 2026.
  • Blue Trust sold 5,102 AstraZeneca shares in Q3 2026, an estimated $850K.
  • AstraZeneca made up 0.02% of Blue Trust's portfolio in Q3 2026, its #193 holding.
  • Blue Trust first reported a position in AstraZeneca in Q2 2022 and has held it in 18 quarters since.
  • Blue Trust's AstraZeneca position peaked at $3.32M in Q2 2026.
  • 1,222 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.

Based on Blue Trust's 13F filing for Q3 2026, filed 15 Oct 2026.